Jeffrey Poulton
Director of Finance/CFO at ALNYLAM PHARMACEUTICALS, INC.
Net worth: 7 M $ as of 30/12/2024
Profile
Mr. Jeffrey V. Poulton is an Independent Director at Homology Medicines, Inc. and a Chief Financial & Accounting Officer at Alnylam Pharmaceuticals, Inc. He is on the Board of Directors at Homology Medicines, Inc., Alnylam UK Ltd. and EIP Pharma, Inc. Mr. Poulton was previously employed as a Chief Financial Officer by Indigo Agriculture, Inc. and a Chief Financial Officer & Executive Director by Shire Plc. He received his undergraduate degree from Duke University and an MBA from Kelley School of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
25/11/2024 | 30,701 ( 0.02% ) | 7 M $ | 30/12/2024 | |
CERVOMED INC.
0.2% | 13/06/2024 | 16,444 ( 0.2% ) | 38 479 $ | 30/12/2024 |
Latest news about Jeffrey Poulton
Jeffrey Poulton active positions
Companies | Position | Start |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 12/08/2019 |
CERVOMED INC. | Director/Board Member | 15/08/2023 |
EIP Pharma, Inc.
![]() EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Director/Board Member | - |
Alnylam UK Ltd.
![]() Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Director/Board Member | 12/08/2019 |
Former positions of Jeffrey Poulton
Companies | Position | End |
---|---|---|
Indigo Ag, Inc.
![]() Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Director of Finance/CFO | 31/03/2019 |
SHIRE | Director of Finance/CFO | 30/12/2017 |
Q32 BIO INC. | Director/Board Member | - |
Training of Jeffrey Poulton
Duke University | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
CERVOMED INC. | Commercial Services |
Private companies | 5 |
---|---|
Shire Plc
![]() Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
EIP Pharma, Inc.
![]() EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
Alnylam UK Ltd.
![]() Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Health Technology |
Indigo Ag, Inc.
![]() Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |
Homology Medicines, Inc.
![]() Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Poulton